Oncoc4, Inc.
Clinical trials sponsored by Oncoc4, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for tough prostate cancer: immunotherapy meets targeted radiation Results expected Nov 2026 (estimated)
- New antibody aims to preserve immune checkpoint while fighting cancer Results expected Dec 2026 (estimated)
- New Dual-Action antibody takes on advanced cancers Results expected Jun 2027 (estimated)
- New antibody drug takes aim at Hard-to-Treat cancers Results expected Aug 2027 (estimated)
- New hope for lung cancer patients: experimental drug aims to extend life after other treatments fail Results expected Aug 2027 (estimated)